WALSH GEORGE J III
SEC CIK 1207140 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHE | CHEMED CORP | Dir | 3,209 | $83.4K | $573.5K | 9 | 2022-05-16 | 2026-05-29 |
Most active insiders at CHE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MCNAMARA KEVIN J | Pres, CEO, Dir | — | $7.63M |
| 2 | LINDELL ANDREA R | Dir | — | $602.6K |
| 3 | LEE SPENCER S | EVP | — | $541.0K |
| 4 | WALSH GEORGE J III | Dir | — | $218.9K |
| 5 | GRACE PATRICK P | Dir | — | $126.6K |
| 6 | Wherley Joel L | CEO - Vitas Healthcare | — | — |
| 7 | McCarthy Eileen P | Dir | — | — |
| 8 | Mount John Meredith Jr. | Dir | — | — |
| 9 | Judkins Brian C | VP, CLO | — | — |
| 10 | Heaney Christopher J | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 15:42 | 2026-05-29 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | S - Sale | $437.83 | -500 | 3,209 | -13% | -$218.9K | |
| 2026-05-19 10:03 | 2026-05-18 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | A - Grant | $440.77 | +386 | 3,709 | +12% | +$170.1K | |
| 2025-08-05 | 2025-08-04 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | P - Purchase | $417.10 | +200 | 3,523 | +6% | +$83.4K | |
| 2025-05-20 | 2025-05-19 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | A - Grant | $579.04 | +277 | 3,323 | +9% | +$160.4K | |
| 2024-09-27 | 2024-09-26 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | S - Sale | $597.47 | -400 | 3,046 | -12% | -$239.0K | |
| 2024-08-22 | 2024-08-21 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | S - Sale | $577.95 | -200 | 3,446 | -5% | -$115.6K | |
| 2024-05-21 | 2024-05-20 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | A - Grant | $564.34 | +284 | 3,646 | +8% | +$160.3K | |
| 2023-05-16 | 2023-05-15 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | A - Grant | $545.69 | +294 | 3,362 | +10% | +$160.4K | |
| 2022-05-17 | 2022-05-16 | CHE | CHEMED CORP | WALSH GEORGE J III | Dir | A - Grant | $496.25 | +262 | 3,064 | +9% | +$130.0K |
Purchase Sale Sale after option exercise All abbreviations